2025 United States Cancer Vaccine Market Revenue Opportunities Report
Description
The 2025 United States Cancer Vaccine Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Cancer Vaccine Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Cancer Vaccine Market in the United States are Merck & Co., Moderna, Inc., Hoffmann-La Roche Ltd. (Roche), and Elicio Therapeutics. Merck leads with innovative strategies and a strong focus on mRNA-based personalized cancer vaccines, notably partnering with Moderna on the mRNA-4157 vaccine targeting solid tumors, and is investing heavily in next-generation therapies. Moderna is known for its pioneering mRNA technology, expanding beyond infectious diseases into cancer vaccines with promising clinical trials demonstrating potential breakthroughs in cancer immunotherapy.
Roche, a Swiss multinational with significant U.S. operations, is known for its robust oncology R&D, integrating diagnostics and treatment to develop cutting-edge cancer vaccines and therapies like monoclonal antibodies that personalize patient care. Elicio Therapeutics, based in Cambridge, Massachusetts, employs its amphiphile (AMP) technology platform to target lymph nodes and enhance immune response, advancing cancer vaccine candidates alongside infectious disease vaccines. These companies form the backbone of the U.S. cancer vaccine landscape, driving progress through innovation, strong clinical pipelines, and strategic partnerships.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Cancer Vaccine Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Cancer Vaccine Market in the United States are Merck & Co., Moderna, Inc., Hoffmann-La Roche Ltd. (Roche), and Elicio Therapeutics. Merck leads with innovative strategies and a strong focus on mRNA-based personalized cancer vaccines, notably partnering with Moderna on the mRNA-4157 vaccine targeting solid tumors, and is investing heavily in next-generation therapies. Moderna is known for its pioneering mRNA technology, expanding beyond infectious diseases into cancer vaccines with promising clinical trials demonstrating potential breakthroughs in cancer immunotherapy.
Roche, a Swiss multinational with significant U.S. operations, is known for its robust oncology R&D, integrating diagnostics and treatment to develop cutting-edge cancer vaccines and therapies like monoclonal antibodies that personalize patient care. Elicio Therapeutics, based in Cambridge, Massachusetts, employs its amphiphile (AMP) technology platform to target lymph nodes and enhance immune response, advancing cancer vaccine candidates alongside infectious disease vaccines. These companies form the backbone of the U.S. cancer vaccine landscape, driving progress through innovation, strong clinical pipelines, and strategic partnerships.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
